Skip to main content
Clinical Trials/NCT05305469
NCT05305469
Recruiting
Not Applicable

Early Identification and Prognosis Prediction of Sepsis Through Multiomics

Yantai Yuhuangding Hospital1 site in 1 country900 target enrollmentJanuary 1, 2022
ConditionsSepsis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sepsis
Sponsor
Yantai Yuhuangding Hospital
Enrollment
900
Locations
1
Primary Endpoint
Pathogen-specific patterns
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

This study aims to integrate multi-omics data and clinical indicators to reveal pathogen-specific molecular patterns in patients with sepsis and establish prognostic prediction models through multiple machine learning algorithms.

Detailed Description

This study aims to quantify the plasma metabolome, single nucleotide polymorphisms (SNPs) of exons and immunocytokines of septic patients with different pathogen infections and prognostic outcomes. Multi-omics data, cytokines, and clinical indicators will be integrated through multiple machine learning algorithms to reveal pathogen-specific molecular patterns and multi-dimensional prognostic prediction models.

Registry
clinicaltrials.gov
Start Date
January 1, 2022
End Date
December 31, 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients with sepsis or septic shock who meet the diagnostic criteria (2016 sepsis 3.0 standard);
  • Age 18~85 years old.

Exclusion Criteria

  • ICU stay of the subjects less than 72 hours;
  • Female subjects who are pregnant;
  • The subjects not sure if infected;
  • The subjects performed CPR;
  • The subjects suffer from chronic renal disease;
  • The subjects with incomplete clinical data.

Outcomes

Primary Outcomes

Pathogen-specific patterns

Time Frame: March 2022 - December 2023

To elucidate the unique infection pathogen-specific molecular patterns in septic patients

Secondary Outcomes

  • Prognostic prediction models(March 2022 - December 2024)

Study Sites (1)

Loading locations...

Similar Trials